During the past decade, Sisli Hamidiye Etfal Training and Research Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 5 clinical trials were completed, i.e. on average, 15.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sisli Hamidiye Etfal Training and Research Hospital" #1 sponsor was "Sisli Hamidiye Etfal Training and Research Hospital" with 21 trials, followed by "Eskisehir Osmangazi University" with 2 trials sponsored, "Health Institutes of Turkey" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sisli Hamidiye Etfal Training and Research Hospital" #1 collaborator was "Arnavutkoy State Hospital" with 2 trials as a collaborator, "Bezmialem Vakif University" with 2 trials as a collaborator, "Bursa Yüksek İhtisas Education and Research Hospital" with 2 trials as a collaborator, "Istanbul Training and Research Hospital" with 2 trials as a collaborator and "Sisli Hamidiye Etfal Training and Research Hospital" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Sisli Hamidiye Etfal Training and Research Hospital" are "Covid19" (3 trials), "Coronavirus Infection" (2 trials), "Hemodialysis" (2 trials), "Acute Diarrhea" (1 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "Sisli Hamidiye Etfal Training and Research Hospital" in a lesser frequency.

Most popular intervention types in "Sisli Hamidiye Etfal Training and Research Hospital" are "Drug" (12 trials), "Other" (10 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bupivacaine Injection" (2 trials), "Ceftolozane/Tazobactam" (2 trials), "CoronaVac" (2 trials) and "Meropenem" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sisli Hamidiye Etfal Training and Research Hospital" are 32 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Sisli Hamidiye Etfal Training and Research Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Sisli Hamidiye Etfal Training and Research Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sisli Hamidiye Etfal Training and Research Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".